Your browser doesn't support javascript.
loading
Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.
Bronsveld, Heleen K; ter Braak, Bas; Karlstad, Øystein; Vestergaard, Peter; Starup-Linde, Jakob; Bazelier, Marloes T; De Bruin, Marie L; de Boer, Anthonius; Siezen, Christine L E; van de Water, Bob; van der Laan, Jan Willem; Schmidt, Marjanka K.
Afiliación
  • Bronsveld HK; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. h.bronsveld@nki.nl.
  • ter Braak B; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. h.bronsveld@nki.nl.
  • Karlstad Ø; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. basterbraak@gmail.com.
  • Vestergaard P; Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway. Oystein.Karlstad@fhi.no.
  • Starup-Linde J; Departments of Clinical Medicine and Endocrinology, Aalborg University, Aalborg, Denmark. p-vest@post4.tele.dk.
  • Bazelier MT; Departments of Clinical Medicine and Endocrinology, Aalborg University, Aalborg, Denmark. Jakob.Linde@auh.rm.dk.
  • De Bruin ML; Department of Endocrinology and Internal Medicine (MEA), Aarhus University Hospital THG, Aarhus, Denmark. Jakob.Linde@auh.rm.dk.
  • de Boer A; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. M.T.Bazelier@uu.nl.
  • Siezen CL; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. M.L.deBruin@uu.nl.
  • van de Water B; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. a.deboer@uu.nl.
  • van der Laan JW; Medicines Evaluation Board (MEB), Utrecht, The Netherlands. cl.siezen@cbg-meb.nl.
  • Schmidt MK; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. water_b@lacdr.leidenuniv.nl.
Breast Cancer Res ; 17: 100, 2015 Aug 05.
Article en En | MEDLINE | ID: mdl-26242987
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Diabetes Mellitus Tipo 2 / Insulina Glargina Tipo de estudio: Etiology_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Límite: Animals / Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Diabetes Mellitus Tipo 2 / Insulina Glargina Tipo de estudio: Etiology_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Límite: Animals / Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos